Myositis-associated autoantibodies in juvenile myositis are associated with refractory disease and mortality.
Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies.
Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis.
Atorvastatin-induced necrotizing autoimmune myositis: An emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype.
Anti-Sp4 autoantibodies co-occur with anti-TIF1 and are associated with distinct clinical features and immunogenetic risk factors in juvenile myositis.
